Clinical Trials Directory

Trials / Completed

CompletedNCT01121874

Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) Arthroplasty

Suture Fixation System Versus Tendonous Reconstruction in Thumb Carpometacarpal Arthroplasty: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
J&M Shuler · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Thumb carpometacarpal (CMC) arthritis affect 1 in 4 females and 1 in 12 males. Patients who fail to respond to conservative treatment may benefit from surgery; however, controversy exists over the most effective surgical technique. A popular technique, ligament reconstruction with tendon interposition (LRTI) involves a trapeziectomy, followed by reconstruction of the palmar oblique ligament using a harvested flexor tendon from the wrist. We believe that use of a suture fixation system to reconstruct the palmar oblique ligament, instead of harvesting a wrist tendon, may provide a superior repair. The objective of this study is to compare functional outcome measurements among patients who receive CMC arthroplasty using a suture fixation system (investigational group) to those who receive LRTI surgery (control group). We hypothesize that patients in the investigational group will demonstrate superior functionality, compared to patients in the control group.

Conditions

Interventions

TypeNameDescription
PROCEDURELigament reconstruction with suture fixation systemCMC arthroplasty consisting of reconstruction of the palmar oblique ligament using a suture fixation system
PROCEDURELigament Reconstruction with Tendon Interposition (LRTI)commonly performed CMC arthroplasty technique, consisting of a trapeziectomy, followed by palmar oblique ligament reconstruction using a harvested flexor tendon from the wrist.
PROCEDURELigament reconstruction with suture fixation systemCMC arthroplasty consisting of reconstruction of the palmar oblique ligament using a suture fixation system, with a decreased period of immobilization from 6 weeks to 2 weeks.

Timeline

Start date
2010-04-12
Primary completion
2012-05-21
Completion
2012-07-25
First posted
2010-05-12
Last updated
2018-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01121874. Inclusion in this directory is not an endorsement.